Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq. By Frank Vinluan on April 01, 2022 1:03 pm. Share. Share Options.

Fong replaced Brad Lerman as Medtronic’s GC, who retired in 2022 before being lured out of retirement to become CLO at ...

Medtronic is bringing on a medical device industry veteran for its new top lawyer as it prepares for a major organizational ...

Ivan Fong, 63, was one of the highest-proifile GCs to sign an amicus brief supporting Perkins Coie's legal challenge of ...

We came across a bullish thesis on Becton, Dickinson and Company on Disruptive Analytics’ Substack by Magnus Ofstad. In this ...

Review the current Becton Dickinson & Co (BDX:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if BDX is the best investment for you.

Becton Dickinson said production of its recently approved rapid test for the coronavirus strain Covid-19 will ramp up to 12 million tests per month by the end of February 2021.

Becton Dickinson's organic growth outlook cut to ~3–4%, down from ~5–6% two years ago. Market-moving news hits Benzinga Pro first—get a 30-minute edge and save 60% this 4th of July.

To enable awareness and knowledge-sharing around best practices of atherothrombectomy in the treatment of vascular diseases a ...